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THE Fc RECEPTOR ON THYMUS-DERIVED LYMPHOCYTES*
I. Detection ofa Subpopulation of Murine T Lymphocytes Bearing the
Fc Receptor
BY ROBERT D. STOUT AND LEONARD A. HERZENBERG
(From the Department ofGenetics, Stanford University School ofMedicine, Stanford,
California 94305)
Studies in several laboratories have shown that mammalian lymphocytes
bear on their surface membranes a receptor which specifically binds aggregated
immunoglobulin (1-6). These studies have shown that the receptor (termed the
Fc receptor) is distinctfrom the complement receptor, is specific for a site on the
Fc portion ofthe aggregated immunoglobulin, and is present predominantly on
B lymphocytes (1-6).
Recently, several reports have suggested that the Fc receptor may be present
on activated T lymphocytes in addition to B lymphocytes (7-9). The functional
significance ofthe Fc receptor on activated T cells, however, remains unclear.
Experiments were initiated in this lab to examine normal murine lymphocytes
bearing the Fe receptor, taking advantage of the fluorescence-activated cell
sorter (FRCS)' and its ability to provide independent volume and quantitative
fluorescence measurements of individual cells as well as its ability to provide
highly purified, functionally viable populations ofthe labeled cells. The present
study describes a significant subpopulation ofnormal T lymphocytes which bear
the Fc receptor and demonstrates that this Fc' T-cell subpopulation does not
include the antigen-specific "helper" T cell.
Materials and Methods
Mice.
￿
Male and female mice from inbred strains of BALB/cN and(SJL x BALB/cN)F, used in
these experiments were obtained from our own colonies at Stanford.
Antisera.
￿
A rabbit antiserum prepared against a saline EDTA extract of rabbit antimouse
thymocyte(RAMT) and absorbed with mouse bone marrow wasshownto be specific forTcells(10).
Rabbit antimouse Ig (RAMIG) was purified by repeated injections of rabbits with ammonium
sulfate prepared mouse Ig in complete Freund's adjuvant. Goat antirabbit Ig(GARIG) was pre-
pared by repeated injections of goats with DEAE-cellulose purified rabbit immunoglobulin in
complete Freund's adjuvant. Anti-Thy 1.2 (antitheta) was prepared by Dr. G. Michael Iverson
from ascites fluid elicited by intraperitoneal injection of Sarcoma 180 cells into AKR mice after
immunization with CBA thymocytes according to the method of Reif and Allen (11). BALB/cN
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'Abbreviations used in this paper. Con A, concanavalin A; D-PBS, Dulbecco's phosphate-
buffered saline; F*(AgAb), fluoresceinated antigen-antibody complexes; FACS, flourescence-acti-
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hemocyanin; OV, ovalbumin; PFC, plaque-forming cell; RAMIG, rabbit antimouse Ig; RAMT,
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antikeyhole limpet hemocyanin (KLH, PacificBiomarine, Venice, Calif) or antieggalbumin (OA,
MilesLaboratories, Inc., Kankakee,111.) wasprepared by intraperitoneal injectionof 100Figalum-
precipitated KLH into 6- to 8-week old BALB/cN mice . 4wk later the mice were boostedwith 100
Wg aqueous KLH administered intravenously. The mice were bled 7 and 10 days after the boost.
The sera were pooled, ammonium sulfate precipitated, andthe 7S fraction purified by chromatog-
raphy on Sephadex G-200. F(ab')Z fragment of the 7S Sephadex G-200 fraction was prepared by
pepsin digestion (1:100 ratio pepsin to protein) at 37°C for 20 h in Walpole's acetate buffer, pH 4.2
(12) and subsequent separation on Sephadex G-200.
All serum preparations were deaggregated by centrifugation at 80,00og for 1 h, sterilized by
passage through a 0.22 wm Millipore filter, and stored at 4°C. Fluorescein conjugates of the
ammonium sulfate-purified Ig of GARIG and AKR anti-Thy 1.2 were prepared according to the
method of Cebra and Goldstein (13) .
Cell Suspensions . Mice were sacrificed by cervical dislocation and the spleens, thymii, and
peripheral lymph nodesexcised. Cell suspensions were prepared by cutting the organs into small
fragments and gently pressing them between two glass slides in Dulbecco's phosphate-buffered
saline (D-PBS) (14) supplemented to 5% vol/vol with fetal calf serum (FCS). All cell suspensions
were dispersed by aspiration with a Pasteur pipette. Connective tissue and tissue clumps were
eliminated by passage through nylon screen. Erythrocytes were eliminated by treatment with
NH,CI buffered in Gey's solution.
Cell Transfer for Adoptive Anti-DNP Responses . The complete methodology foradoptive trans-
fer and subsequent plaque assay has been published previously (15). Briefly, splenic B lympho-
cytes, prepared from spleens of DNP-KLH primed mice by treatment with anti-Thy 1 plus
complement, were transferred to lethally irradiated syngeneic recipients along with nylon wool-
purified splenic Tcellsand100jig aqueous DNP-KLH. Therecipientspleenswere removed7days
later and assayed for direct and indirect anti-DNP PFC by a modification of the plaque assay
described by Cunningham and Szenberg (16).
Fluorescence Staining of Cells.
￿
Pelleted cells (1 x 10') were resuspended in 0.1 ml of the
labeling reagent (0.5 mg/ml RAMT, 1.2 mg/ml RAMIE, 0.5 mg/ml fluoresceinated anti-Thy 1.2)
and left at room temperature for 20 min. The cell suspension was pelleted through FCS and
subsequently washed in 2 ml of medium. Except in the case of directly fluoresceinated anti-Thy
1.2, thecell pelletswere resuspended in 0.1 ml of fluoresceinated GARIG at 0.4 mg/ml and left at
room temperature for 20 min. Thecellswere washed as above, resuspended to 2-5 x 106cells/ml in
D-PBS, and held on ice for analysis.
Labeling of Fe Receptor.
￿
Fluoresceinated antigen-antibody complexes were prepared by add-
ing a 10- to 20-foldexcess of7S anti-KLH to fluoresceinated KLH, incubating 2h at 37°C, andthen
overnight at 4°C. The fluoresceinated antigen-antibody complexes (F"(AgAb)) were pelleted by
centrifugation at 30,0008 andresuspended in D-PBSto 1 mg protein perml. Pelleted cells (1 x 10')
were resuspended in 0.1 ml of the fluoresceinatedcomplexesand incubatedat 37°C for30 min. The
cells were pelleted through 1 ml of FCS and subsequently washed in 2 ml of D-PBS.
Fluorescence Microscopy. A Zeiss microscope with an HB200 mercury arc (OSRAM) light
source was used (Carl Zeiss, Inc., New York). Cells were examined with dark-field illumination
usinga Zeiss 1.2/1.4 NA oil immersionplanochromat objective with an iris diaphragm. Combina-
tion of a Zeiss PIL 546 NM excitation filter and two layers of Kodak Wratten no. 23A gelatin
barrier filter (Eastman Kodak Co., Rochester, N. Y.) were used to detect fluorescence.
Cell Separation.
￿
Immunoglobulin-bearing cells were removedfrom spleen cell suspensions by
passage through nylonwool accordingto the method of Julius et al. (17) . Briefly, 0.6 g nylon wool
(LP-1) Leuko-Pakleukocyte filters (Fenwal Laboratories, Morton Grove, Ill.) were packed into the
barrel of a 12 ml syringe up to the6ml mark andthoroughly wetted with D-PBS. Thecolumn was
incubated at 37°C for at least 1 h and washed with 50-80 ml ofwarm (37°C) D-PBS. The columns
were sealed with parafilm and incubated at 37°C for 45 min. The column wasthen washed slowly
with 24 ml of warm D-PBS and the effluent, which containedahighly pure population of Tcells,
(Table II), collected. The nylon wool was then removedfrom the column, eluted with 50-80 ml of
cold (4°C)D-PBS, and the eluate, which was enriched forIg-bearing cells(Table 11), wascollected.
Viability, as determined by trypan blue dye exclusion, was usually greater than 90%.
Cells labeled with fluoresceinated anti-Thy 1.2 or AgAb were separated from unlabeled cells
using a FACS as previously described (18-20). In the latest version, FACS-1, (made by Becton
Dickinson Electronics Laboratory, Mountain View, Calif.) of this instrument, cellswere observedROBERT D. STOUT AND LEONARD A. HERZENBERG
individually in suspension in thecentral stream ofa70,um diameter coaxial liquidjet as it passes
throughalaserbeam. One photodetector system provides a measureof cell size by detectinglight-
scattering characteristics and a second photo detector system provides a quantitative measure of
fluorescence intensityusing appropriate opticalfilters. The liquid jetis laterbroken into uniform-
sized droplets, and those droplets containing the desired cells are charged electrically and
deflected in an electric field. The cell populations separated in these experiments were processed
at a rate of 5,000 viable cells per second, which permitted a substantial enrichment of positive
fractions and virtually 100% pure negative fractions (see Table 1).
Analysis ofCell Populations on the FRCS.
￿
Analysis of cell populations on the FACS involved
the same principles as involved in cell separation described above. Cells were processed at 500-
1,000 cells per second and the intensity of fluorescence (pulse height) was recorded for each
individual cell on thepulseheight analyzer. Thelevel ofbackground fluorescence wasdetermined
by analyzingappropriate negative controls (e.g., cells labeled with normal rabbit serum). Thus,
the percentage of labeled cells was obtained by counting the number of cells giving fluorescence
signals above background and dividing by the total number of viable cells examined. Light-
scattering signals distinguish live from dead lymphocytes (20). This calculation was performedby
the FACS analyzer and was based on analysis of 5-10 x 10' individual viable cells.
Results
Exposure ofsingle cell suspensions ofspleen from 12-wk old BALB/cN mice to
200 Ag of fluoresceinated KLH-anti-KLH complexes (F*(AgAb)) resulted in
labeling of approximately 65% of the cells (Fig. 1). This level of labeling
represents saturation of the binding cell population insofar as further increases
in concentration ofF*(AgAb) did not increase the number of spleen cells labeled.
At saturation (200 Ag F*(AgAb)), the fluorescence distribution of the labeled
spleen cells (i.e., the fluorescence intensity per cell) was very broad, indicating a
large variation in the amount of F*(AgAb) bound per cell in the splenic lympho-
cyte population (Fig. 2)
v
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FIG. 1. Optimal concentration of F*(AgAb) for labeling of spleen and thymus cell popula-
tions. 10 million spleen or thymus cells were incubated 30 min at 37'C with 10-1,000 dug of
F*(AgAb), washed through FCS, and analyzed on the FACS.
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- - - Spleen (F*KLH alone) : 3':', >10 Fluorescence Units
Spleen (F*KLHaKLH) : 56" X10 Fluorescence Units
50 100 150 200 250
Relative Fluorescence Intensity Per Cell
FIG. 2 . Fluorescence distribution of spleen cells labeled with F*(AgAb) . 10 million spleen
cells were incubated 30 min at 37°C with 200 jig of F*KLH or 200 jig of F*KLH anti-KLH
complexes, washed through FCS, and analyzed on the FACS. The distribution curve is
based on cumulative analysis of 25,000 viable cells.
To establish the specificity of the binding of F*(AgAb) to spleen cells, com-
plexes were prepared with F*KLH and 19S (IgM) anti-KLH, 7S anti-KLH, or
F(ab')2 anti-KLH. Exposure ofspleen cells to 200 leg ofcomplexes prepared with
7S anti-KLH resulted in labeling of 60% of the cells (Table I). Similar exposure
of spleen cells to 200 jig of complexes prepared with either 19S anti-KLH or
F(ab')2 anti-KLH resulted in labeling of less than 5% of the cells. Complexes
prepared with fluoresceinated egg albumin (F*OA) and 7S anti-OA labeled the
splenic lymphocytes to the same extent as complexes prepared with F*KLH and
7S anti-KLH (Table I). Thus, the labeling ofspleen cells with F*(AgAb) was due
to binding of the Fc portion of 7S antibody and was independent ofthe antigen
binding specificity of that antibody.
The number of Fc+ cells in spleen consistently exceeded the number of Ig-
bearing cells (54% and 43%, respectively, in Table II). To determine the identity
of these Fc+ Ig- cells, spleen cells, before and after separation on nylon wool,
were stained for membrane Ig (RAMIG), T-cell markers (RAMT), and/or the Fc
receptor. Inthe intact spleen cell population, 9% ofthe cells were labeledbyboth
the anti-T cell (RAMT) and the F*(AgAb) reagents (Table II). In the effluent
fraction of the nylon wool separated spleen cells, 98% of the cells were labeled
with RAMT, 18% of which were labeled with F*(AgAb) (Table II). Similar
results were obtained using an AKR anti-CBA Thy 1.2 serum instead ofRAMT.
When the amount ofF*(AgAb) bound per cell (fluorescence distribution) by the
purified splenic T lymphocytes was compared with that bound per cell by the
population enriched for splenic lymphocytes (nylon wool effluent and eluate,
respectively, Table II), no significantdifference was observed (Fig. 3). Although
the number of labeled cells was higher in the B-cell-enriched population, bothROBERT D. STOUT AND LEONARD A. HERZENBERG
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TABLE I
Specificity of the Fe Receptor for 7S Antibody
* 10°Spleen cellswere incubated30 minat 37°C with 200Wg of indicated
complexes, washed through FCS, and analyzed on the FACS.
f Numerical values represent arithmetic mean of five experiments ± 1
SD.
TABLE II
Presence ofFc Receptor on Peripheral T Cells
Cells*
Cells
￿
T' and
Ig+ T' Fc+ Fc+
(Doubles)
Unseparated spleen
￿
43
￿
41
￿
54
￿
9
Nylon wool effluent
￿
1
￿
98
￿
18
￿
16
Nylon wool eluate
￿
65
￿
25
￿
78
￿
8
* Cells were labeled with RAMIG or RAMG followed by rhodaminated
G or RIG ± F* (AgAb) or with F* (AgAb) alone. Percentage of cells
labeled is based on microscope analysis of 200-400 cells.
cell populations displayed cells labeling with the complexes over a broad range
of fluorescence intensity.
The tissue distribution of the Fc+ lymphocytes was examined by labeling
lymphocytes from spleen, peripheral lymph nodes, and thymus with RAMT
(rhodamine) and F*(AgAb) (fluorescein) and counting the number of cells bear-
ing both labels under a fluorescent microscope. As can be seen in Table III, the
percentage of T lymphocytes bearing Fc receptor was approximately the same
(-23%) in spleen and lymph node. Thymus contained a smaller subpopulation
(-V10%) of cells bearing the Fc receptor (Table III and Fig. 1).
To investigate the previously proposed hypothesis (8) that the Fc' T lympho-
cytes are antigen-activated T cells (e.g., lymphoblasts and/or cooperator T cells),
the size distribution of the Fc+ splenic T cells (those T cells having fluorescence
intensity greater than 10 U as displayed in Fig. 3) was compared with the size
distribution of the Fc- T cells (those T cells having a fluorescence intensity of
less than 10 U). As can be seen in Fig. 4, the size distribution of the Fc+ andFc-
T cells were essentially similar-both populations displayed a predominance
(>70%) of small cells with a minor (13% of Fc- and 28% of Fc+) population of
Labeling reagent* Spleen cells labeled$
F*KLH 1.8 ± 0.8
(F*KLH + 19SaKLH) 4.0 ± 2.0
(F*KLH + 7SaKLH) 58 ± 7
(F*KLH + F(ab')zaKLH) 4.2 ± 2.3
(F*OA + 7SaOA) 62 ± 5616
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TABLE III
Frequency ofFc+ T Lymphocytes in BALBleN Lymphoid Tissue
v
U
W
O
L
d
E
Z
d
* Cells were labeled with RAMT followed by rhodaminated GARIG plus F*
(AgAb) . Fraction of cells labeled is based on microscope analysis of 200-500
cells . Numerical values represent arithmetic mean ± SD of three experi-
ments.
50 100 150 200 250
Relative Fluorescence Intensity Per Cell
FIG. 3 . Fluorescence distribution of nylon wool purified splenic B and T cells labeled with
F*(AgAb). 10 million nylon wool purified splenic B cells (69% Ig+) or splenic T cells (<1% Ig+) were
incubated 30 minat 37°C with 200 ILg F*(AgAb), washed throughFCS, and analyzed on the FACS.
The distribution curves are based on cumulative analyses of 25,000 viable cells.
large cells (those cells having a size greater than 135 U as displayed in Fig. 4) .
To determine whether the Fc+ T lymphocytes are capable of cooperating with
B lymphocytes in the humoral immune response to DNP-KLH, splenic T cells
from (SJL x BALB)F, mice primed 1 wk previously with 100 wg alum-precipi-
tated KLH were purified by nylon wool filtration, labeled with complexes of
F*OA-7S anti-OA, and separated on the FACS into Fc+ (23% of T cells) and Fc-
(77% of T cells) fractions. Graded numbers of these 1 wk KLH-primed T lympho-
cytes were then transferred into lethally irradiated syngeneic recipients along
with 100 jig DNP-KLH and 5 x 10' anti-theta plus complement-treated spleen
cells from (SJL x BALB)F, mice primed 1 mo previously with 100 Wg alum-
Tissue
T+/total
Fraction of
Fc+/total
labeled cells*
Fc+T+/total Fc+T+/T+
Spleen 0.46 -t 0.08 0.61 ± 0.10 0.11 ± 0.04 0.24
Lymphnode 0.75 t: 0.09 0.38 ± 0.08 0.16 ± 0.06 0 .22
Thymus 0.97 - 0.02 0 .10 ± 0.04 - -ROBERT D. STOUT AND LEONARD A. HERZENBERG
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FIG. 4. Size distribution of Fc* vs. Fc- splenic T cells. 10 million nylon wool purified splenic T
lymphocytes (<l% Ig+) were incubated 30 min at 37°C with 200 leg F*(AgAb), washed through
FCS, andanalyzed on the FACS. Thesize distributions of 25,000 cells labeling with afluorescence
intensity ofgreater than 10 U (Fc+ T, as shownin Fig. 3) or less than 10 U We T) are represented.
250
precipitated DNP-KLH (DNP-primed splenic B cells). 1 wk later, the recipient
spleens were assayed for direct and indirect DNP specific PFC . As can be seen in
Fig. 5, recipients of 5 x 106 DNP primed splenic B cells without KLH-primed T
lymphocytes responded very poorly (<50 indirect DNP-PFC/106 spleen cells).
This response increased linearly with increasing doses of KLH-primed T cells up
to 5,100 indirect DNP-PFC/106 spleen cells of recipients receiving 3 x 106
unseparated T cells. Recipients of 0.75 x 106 Fc+ T cells, which constituted 23%
of the splenic T-cell population and therefore were equivalent to 3 x 106
unseparated T cells, did not mount a significant indirect DNP-PFC response
(300 PFC/106 recipient spleen cells). Recipients of 1 .5 x 106 Fc- T cells responded
as well as recipients of 1 .5 x 106 unseparated T cells-3,116 DNP-PFC/106 cells
and 2,700 PFC/106 cells respectively. The same result was obtained when splenic
T cells from donors primed with KLH 1 mo previously were used.
Discussion
Utilizing the FACS and murine antibody-antigen complexes formed in anti-
body excess, we have demonstrated the presence of the Fc receptor on the
surface of a distinct subpopulation of murine T lymphocytes. The fluorescence
distributions of F*(AgAb)-labeled B and T cells were both very broad, indicating
a large variation in the amount of complexes bound per cell. This lack of
uniformity of staining is in accord with the great heterogeneity in the number of
Fc receptors per cell reported by Andersson and Grey (9). The fluorescence
distributions of the labeled T- and B-cell populations were almost completely
overlapping. Thus, there appeared to be no significant difference in the amountNumber of T Cells Transferred (x 106 )
FiG. 5. Cooperator activity of Fc+ vs. Fc- splenic T cells. Splenic T cells were prepared by nylon
wool filtration of spleen cells from mice primed 1 wk previously with 100 Wg KLH. 100 million T
cells were labeled with 2 mg F*OA anti-OA complexes and separated into Fe' (fluorescence
intensity greater than 10 U, Fig. 3) and Fc- (fluorescence intensity less than 10 U, Fig. 3) on the
FACS. Graded numbers of these T cells (0-3 x 108) were transferred into lethally irradiated
recipients along with 100 I~gDNP-KLHand 5 x 108 antitheta-treated DNP-KLH-primed splenic B
cells. 1 wk later therecipient spleens were pooled and assayed for direct and indirect DNP-PFC.
Thenumber of indirect DNP-PFC per108spleen cells arepresented as afunction ofnumber Tcells
transferred.
ofcomplexes bound per cell between the peripheral Fc+ T and B lymphocytes.
Several groups have recently reported that the Fe receptor appears on T
lymphocytes activated by exposure to KLH (8) or allogeneic cells (7, 9). We have
also found an increase in the number of Fc+ T cells as a result of allogeneic
activation (unpublished observation). The data reported here, however, suggest
that the state of activation and the presence ofthe Fe receptor on T lymphocytes
are not strictly correlated. First, the majority (70%) of Fc+ T cells in normal
spleen cell populations are small lymphocytes (e .g., not lymphoblasts) . This
indicates that the T lymphocytes do not need to be in an activated state to
express the Fc receptor. Secondly, only 50-60% of the large "activated" T cells
bear the Fc receptor (7-9), suggesting that activation does not always lead to
acquisition of the Fc receptor. Finally, it was reported that KLH-activation of T
lymphocytes resulted in a substantial increase in Fc+ T cells (8). However, as
shown in this study, the Fc+ T lymphocytes isolated from spleen 1 wk after
priming with KLH did not cooperate with DNP-primed B lymphocytes to give an
adoptive PFC response to DNP-KLH. Rather, all ofthe T-cell helper activity, on
a per cell basis, was recovered in the Fc- T-cell population. Thus, we find that
the reported increase in Fc+ T lymphocytes upon antigen-activation appears to
be irrelevant to the functional (cooperator) activation which occurred.
The question thus arises as to why activation leads to an increase in Fc+
lymphocytes and/or what the function of the Fc+ T lymphocytes is . The lack of
cooperator activity of Fc+ T cells isolated from mice 1 wk or 1 mo after carrierROBERT D. STOUT AND LEONARD A. HERZENBERG
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priming makes it unlikely that the Fe receptor is a general marker for primed T
cells. However, due to the observed increase in numbers of Fc+ T cells upon
exposure to activating conditions, we cannot exclude the possibility that the Fe
receptor may be a marker for differentiation in subsets of T cells other than the
cooperator T cells (21, 22) .
Cantor et al. have described two T-cell subsets which can be distinguished on
the basis of Thy 1.2 density (22) and anatomical localization (23), one subpopula-
tion (T,) being primarily restricted to thymus and spleen and the second subpop-
ulation (T2) being primarily restricted to lymph node and blood. Since an
equivalent proportion of the T cells in lymph node and spleen bear the Fc
receptor (Table III) it is unlikely that the Fc+ T cell is restricted to either the T,
or TZ subpopulations.
Gorczynski et al. (24) have recently attempted to explain the bulk ofimmuno-
suppression phenomena in terms of blocking of lymphocyte function by antigen-
antibody complexes. Their arguments are based on two hypotheses: first, that
an Fc receptor exists on T lymphocytes; and second, that the Fc receptor or the
cell bearing that receptor exerts a control function. The presence of an Fc
receptor on a distinct subpopulation of murine T lymphocytes has been demon-
strated in this report, thus confirming their first hypothesis . Their second
hypothesis would predict that the Fc+ T cells may be active in one or more of the
suppressor T-cell systems described by many laboratories (25-31) . The role of
Fc+ T cells in active immunosuppression in these systems is at present under
investigation. The data available at this time (unpublished observation) indi-
cate that the Fc+ T cells do not include the suppressor T cells responsible for the
allotype-specific suppression described by the Herzenbergs (25). It has been
demonstrated that concanavalin A (Con A) stimulation of T lymphocytes results
in a nonspecific suppression of antibody responses, the suppression being me-
diated by a soluble factor (29, 31) . The Fc+ T cells described in the present report
have been shown to respond very well to Con A whereas the Fc- T cells respond
very poorly or not at all to this mitogen.z Therefore, the Fc+ T cells are likely
candidates for the cells involved in this Con A-induced nonspecific suppressor
mechanism .
Finally, it is, of course, possible that the Fc+ T lymphocytes are involved in
cell-mediated immunity. The increase in T cells bearing the Fc receptor as a
result of allogeneic activation (7, 9) suggests that this may be the case. Indeed,
the increase in Fc+ T cells as a result ofculture with KLH (8) might be explained
by a cellular immune reaction to KLH. We are, therefore, currently investigat-
ing the ability of Fc+ and Fc- T lymphocytes to participate in cell-mediated
immune reactions.
Summary
Utilizing the fluorescence-activated cell sorter (FACS) and washed murine
antibody-antigen complexes formed in antibody excess, we have demonstrated
the presence of the Fc receptor on the surface of a distinct subpopulation of
2 Stout, R., and L. A. Herzenberg. The Fe receptor on thymus-derived lymphocytes. II. Mitogen
responsiveness ofTlymphocytes bearing the Fc receptor. Manuscript submitted for publication.620
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murine T lymphocytes. No differences in intensity of labeling with the com-
plexes was observed when the Fc+ T lymphocytes were compared with Fc+ B
lymphocytes . The majority of Fc+ T lymphocytes are small lymphocytes as
determined by light-scattering characteristics on the FAGS. Separating Fc+
from Fc- T lymphocytes from spleens of mice primed 1 wk or 1 mo previously
with keyhole limpet hemocyanin (KLH) revealed that the T cells capable of
cooperating with DNP-KLH primed B cells to give an adoptive anti-DNP PFC
response do not bear the Fc receptor.
The authors wish to express their gratitude to Dr. Ko Okumura, Mr. Timothy Gadus, and Mr.
Theta Tsu for their assistance in performing the adoptive transfers and plaque assays; to Mr.
Timothy Knaak and Mr. Richard Stovel for theirassistancewith the cell separations on the FAGS;
and to Ms. Virginia Bryan for her excellent technical assistance throughout this study.
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